Enliven Therapeutics
ELVN
#5218
Rank
S$1.57 B
Marketcap
$33.27
Share price
5.84%
Change (1 day)
78.01%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$28.8 M

According to Enliven Therapeutics's latest financial reports the company's total liabilities are S$28.8 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$34.28 M-84.03%
2022-12-31S$0.21 B1.89%
2021-12-31S$0.21 B5.32%
2020-12-31S$0.20 B